AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

EXEMESTANE

14 registrations across 6 African markets— 10 active

Markets with EXEMESTANE

Recent registrations

Brand / ProductMarketHolderStatusExpires
EXEMEX 25
TABLET, COATED; ORAL
🇿🇼ZimbabweINNOVATA PHARMACEUTICALSactiveAug 2028
EQUISIN
TABLET, COATED; ORAL
🇿🇼ZimbabweEQUITY PHARMACEUTICALS (PTY) LTDactiveDec 2027
EXEDRAL
TABLET, COATED; ORAL
🇿🇼ZimbabweREMEDICA LTDactiveDec 2027
Aromasin Tablets 25 mg**
Tablet
🇳🇬NigeriaPfizer Specialties LtdactiveNov 2025
EXMA🇿🇦South AfricaPharmaplan (Pty) LtdsuspendedDec 2023
EXEMESTANE ACCORD
Comprimé pelliculé / 25 mg
🇹🇳TunisiaACCORD HEALTHCARE LTDexpiredMay 2017
AROMAPLEX
Comprimé pelliculé / 25 mg
🇹🇳TunisiaGENEPHARM S.AexpiredSept 2016
AROMASINE
Comprime enrobé / 25 mg
🇹🇳TunisiaPFIZER HOLDING FRANCEexpiredFeb 2006
EQUISIN🇿🇦South AfricaEquity Pharmaceutical (Pty) LtdactiveJan 1900
EXEMESTANE 25 mg ACTIVO🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
EXICAN🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 1900
AROMASIN 25 mg🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
AROMASINE
COMPRIME ENROBE
🇲🇦Moroccoactive
AROMASINE 25MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoirePFIZER SPECIALTIES LIMITEDactive

EXEMESTANE in Africa — Regulatory Overview

EXEMESTANE is registered across 6 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Zimbabwe, Côte d'Ivoire and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 10 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.